Zobrazeno 1 - 10
of 51
pro vyhledávání: '"J. Gratacos-Masmitja"'
Autor:
E. Casado, S. Garcia-Cirera, S. Retamozo, M. Rusiñol, E. Costa Moya, L. Lluís, J. Calvet, J. Gratacos-Masmitja
Publikováno v:
Annals of the Rheumatic Diseases. 81:192.2-192
BackgroundRotator cuff calcific tendinopathy is a common cause of shoulder pain and disability in young patients. Despite analgesics or steroid injection some patients still experience symptoms and may require surgery. Ultrasound-guided fragmentation
Autor:
M. Garrido-Cumbrera, E. Collantes-Estévez, V. Navarro-Compán, P. Zarco-Montejo, C. Sastré, J. Correa-Fernández, J. Gratacos-Masmitja
Publikováno v:
Annals of the Rheumatic Diseases. 81:1532-1532
BackgroundHealthcare utilization by patients with axial spondyloarthritis (axSpA) is substantial, leading to a considerable social and economic burden1. Understanding patients’ characteristics and the main determinants of healthcare utilization is
Autor:
C. Orellana, M. Rusiñol, E. Costa Moya, J. Calvet, S. Garcia-Cirera, M. Garcia Manrique de Lara, C. Galisteo, J. Gratacos-Masmitja
Publikováno v:
Annals of the Rheumatic Diseases. 81:895.2-895
BackgroundIrisin is a myokine synthesized mainly in skeletal muscle with exercise, although its secretion has also been observed in other tissues such as adipose and has been related to obesity and other metabolic alterations. Although obesity and ot
Autor:
R. Queiró Silva, D. Seoane-Mato, A. Laiz, E. Galíndez-Agirregoikoa, J. D. D. Cañete, J. Gratacos-Masmitja, X. Juanola-Roura, J. Fiter, A. González Marcos
Publikováno v:
Annals of the Rheumatic Diseases. 81:405.2-406
BackgroundAn important aspect in the clinical care of patients with PsA is to be able to predict the occurrence of a flare using tools and information that are readily available in daily clinical practice. This information would provide added value i
Autor:
S. Garcia-Cirera, C. Galisteo, S. Retamozo, M. Moreno, E. Casado, E. Costa Moya, J. Gratacos-Masmitja, J. Calvet
Publikováno v:
Annals of the Rheumatic Diseases. 81:1039.2-1039
BackgroundSalivary gland ultrasonography is useful to assess salivary gland involvement in primary Sjögren Syndrome. Different publications have describes the association between decreases salivary flow and the degree of involvement with ultrasound.
Autor:
C. Galisteo, S. Garcia-Cirera, S. Retamozo, M. Moreno, E. Casado, M. Rusiñol Gonzalez, J. Calvet, J. Gratacos-Masmitja
Publikováno v:
Annals of the Rheumatic Diseases. 81:678.1-678
BackgroundSalivary glands ultrasound is an imaging technique useful for primary Sjogren’s syndrome (pSS) diagnosis. Nowadays, the use of ultrasound in diagnostic criteria is not clear. Different scoring systems have been published in recent years.O
Autor:
S. Garcia-Cirera, C. Galisteo, S. Retamozo, M. Moreno, E. Casado, M. Rusiñol Gonzalez, J. Gratacos-Masmitja, J. Calvet
Publikováno v:
Annals of the Rheumatic Diseases. 81:268.1-268
BackgroundThe origin of the histological chronic inflammation of the salivary gland in patients with primary Sjogren’s Syndrome (pSS) is questionable. It is probably a consequence of both, the evolution of the disease itself and ageingObjectivesThi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marco Garrido-Cumbrera, P. Zarco-Montejo, P. Plazuelo-Ramos, C. Sastré, Eduardo Collantes-Estevez, Victoria Navarro-Compán, J. Gratacos-Masmitja, S. Sanz-Gómez
Publikováno v:
Annals of the Rheumatic Diseases. 80:764-765
Background:Sleep is an essential aspect of health that is commonly disrupted in patients with axial spondyloarthritis (axSpA).Objectives:This analysis aims to assess the prevalence and associated factors of sleep disorders in a large sample of axSpA
Autor:
Arthur Kavanaugh, F. Behrens, Weibin Bao, Dafna D. Gladman, Ruvie Martin, P. Nash, Corine Gaillez, Philippe Goupille, J. Gratacos-Masmitja, Laura C. Coates, I. McInnes, P. J. Mease
Publikováno v:
Annals of the Rheumatic Diseases. 80:797-798
Background:EXCEED (NCT02745080) was the first fully blinded head-to-head trial to evaluate the efficacy and safety of secukinumab (SEC) versus (vs) adalimumab (ADA) monotherapy in patients with active psoriatic arthritis (PsA) with a primary endpoint